Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK1012 Inhalation Solution for Pediatric RSV Lower Respiratory Tract Infection
CTR20260414Phase 3Active
- Sponsor
- Anke Bio
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of AK1012 in respiratory syncytial virus disease (RSV), pneumonia, bronchiolitis, sponsored by Anke Bio. Started Mar 2026; status: active.
02
Drugs
AK1012
03
Conditions
respiratory syncytial virus disease (RSV)pneumoniabronchiolitis
Beyond the preview
Go deeper on CTR20260414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260414.